Low-grade gliomas in adults.

Low-grade gliomas are a heterogeneous group of neoplasms usually encountered in younger patient populations. These tumors represent a unique challenge because most patients will survive a decade or more and may be at a higher risk for treatment-related complications. Clinical observations over the years have identified a subset of low-grade gliomas that tends to manifest more aggressive clinical behavior and require earlier, more aggressive intervention. Clinical and molecular parameters may allow better assessment of prognosis and application of risk-adjusted management strategies that may include resection, radiation, or chemotherapy. Improved methods of long-term cognitive and functional assessment are desperately needed in this patient population.

[1]  J. Drake,et al.  Management and outcome of low-grade astrocytomas of the midline in children: a retrospective review. , 1993, Neurosurgery.

[2]  K. Hoang-Xuan,et al.  Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  M Teräs,et al.  Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma. , 2000, International journal of radiation oncology, biology, physics.

[4]  S. Ashley,et al.  Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  A. Karim,et al.  A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. , 1996, International journal of radiation oncology, biology, physics.

[6]  K. Fulling,et al.  The value of radiation therapy in addition to surgery for astrocytomas of the adult cerebrum , 1985, Cancer.

[7]  M. Chintagumpala,et al.  Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children , 2005, Cancer.

[8]  M. Berger,et al.  Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. , 2001, Journal of neurosurgery.

[9]  Mixed oligoastrocytomas: a survival and prognostic factor analysis. , 1994 .

[10]  T. Lawrence,et al.  Radiotherapy: what can be achieved by technical improvements in dose delivery? , 2005, The Lancet. Oncology.

[11]  G. Giles,et al.  Occupational risk factors for low grade and high grade glioma: Results from an international case control study of adult brain tumours , 2005, International journal of cancer.

[12]  B. Scheithauer,et al.  Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  M. Prados,et al.  Treatment options and prognosis for multicentric juvenile pilocytic astrocytoma. , 1994, Journal of neurosurgery.

[14]  L. Recht,et al.  Low-grade gliomas. , 1995, Neurologic clinics.

[15]  S. Gerson Clinical relevance of MGMT in the treatment of cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  H. Mehdorn,et al.  Management of tectal glioma in childhood. , 2005, Pediatric neurology.

[17]  A. Twijnstra,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Presenting Symptoms and Imaging of Grade Ii Astrocytoma Supratentorial Grade Ii Astrocytoma: Biological Features and Clinical Course , 2022 .

[18]  D. Miller,et al.  Cervicomedullary tumors in children , 1994, Neurology.

[19]  L. Recht,et al.  Suspected low‐grade glioma: Is deferring treatment safe? , 1992, Annals of neurology.

[20]  Laurent Capelle,et al.  Continuous growth of mean tumor diameter in a subset of grade II gliomas , 2003, Annals of neurology.

[21]  D. J. Lacey,et al.  Prognostic factors in brainstem gliomas , 1986, Neurology.

[22]  P. Wesseling,et al.  Molecular pathogenesis of oligodendroglial tumors , 2004, Journal of Neuro-Oncology.

[23]  H. B. Marsden,et al.  Patterns of multiple primary tumours in patients treated for cancer during childhood. , 1987, British Journal of Cancer.

[24]  G. Draper,et al.  Incidence of second primary tumours among childhood cancer survivors. , 1987, British Journal of Cancer.

[25]  B. Scheithauer,et al.  Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  E. Shaw,et al.  Prospective clinical trials of intracranial low-grade glioma in adults and children. , 2003, Neuro-oncology.

[27]  M. Leach,et al.  Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy , 2004, British Journal of Cancer.

[28]  M. Berger,et al.  The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas , 1994, Cancer.

[29]  G. Reifenberger,et al.  Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. , 1994, The American journal of pathology.

[30]  M. Berger,et al.  Pediatric brain stem tumors: radiographic, pathological, and clinical correlations. , 1983, Neurosurgery.

[31]  J. Fazekas,et al.  Treatment of grades I and II brain astrocytomas. The role of radiotherapy. , 1977, International journal of radiation oncology, biology, physics.

[32]  Edward E Graves,et al.  Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy. , 2002, International journal of radiation oncology, biology, physics.

[33]  J. Cairncross,et al.  Low-grade glioma. To treat or not to treat? , 1989, Archives of neurology.

[34]  D. Áfra,et al.  Supratentorial recurrences of gliomas. Morphological studies in relation to time intervals with astrocytomas , 2005, Acta Neurochirurgica.

[35]  W. Shapiro,et al.  Low-grade glioma: Supratentorial astrocytoma, oligodendroglioma, and oligoastrocytoma in adults , 2004, Current neurology and neuroscience reports.

[36]  Allan H Friedman,et al.  Phase II trial of temozolomide in patients with progressive low-grade glioma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  Philippe Cornu,et al.  Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. , 2002, International journal of radiation oncology, biology, physics.

[38]  L. Deangelis,et al.  Long-term outcome of low-grade oligodendroglioma and mixed glioma , 2000, Neurology.

[39]  Management and Outcome of Low-Grade Astrocytomas of the Midline in Children , 1993 .

[40]  M. Piérart,et al.  Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial , 2005, The Lancet.

[41]  M. Chiang,et al.  Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma , 2005, Journal of Neuro-Oncology.

[42]  S. Goldman,et al.  Combined use of 18F-fluorodeoxyglucose and 11C-methionine in 45 positron emission tomography-guided stereotactic brain biopsies. , 2004, Journal of neurosurgery.

[43]  S. Coons,et al.  The prognostic significance of Ki-67 labeling indices for oligodendrogliomas. , 1997, Neurosurgery.

[44]  E. Eskandar,et al.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 33-2004. A 34-year-old man with a seizure and a frontal-lobe brain lesion. , 2004, The New England journal of medicine.

[45]  I. Ercan,et al.  High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. , 2005, Clinical radiology.

[46]  A. Chiò,et al.  Prognostic Factors in Oligodendroglioma , 1997, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[47]  M. Berger,et al.  Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. , 2002, Journal of neurosurgery.

[48]  M. Citron,et al.  Pyrimidine dimer removal enhanced by DNA repair liposomes reduces the incidence of UV skin cancer in mice. , 1992, Cancer research.

[49]  D. Kondziolka,et al.  Survival after stereotactic biopsy and irradiation of cerebral nonanaplastic, nonpilocytic astrocytoma. , 1995, Journal of neurosurgery.

[50]  R. Gonzalez,et al.  MRI in treatment of adult gliomas. , 2005, The Lancet. Oncology.

[51]  M. Bent Can chemotherapy replace radiotherapy in low-grade gliomas? Time for randomized studies. , 2003 .

[52]  M. J. van den Bent,et al.  Successful treatment of low‐grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine , 2005, Cancer.

[53]  C. Lui,et al.  Treatment outcomes and prognostic factors of patients with supratentorial low-grade oligodendroglioma. , 2002, International journal of radiation oncology, biology, physics.

[54]  T E Schultheiss,et al.  Radiation response of the central nervous system. , 1995, International journal of radiation oncology, biology, physics.

[55]  D. Áfra,et al.  Recurrent Low-Grade Gliomas: Dedifferentiation and Prospects of Reoperation , 1991 .

[56]  J. Jolles,et al.  Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study , 2002, The Lancet.

[57]  J. Henson,et al.  Age-dependent rate of anaplastic transformation in low-grade astrocytoma , 1999, Neurology.

[58]  A. Paetau,et al.  Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients , 2001, Neurology.

[59]  A. Karim,et al.  Prognostic factors for survival in adult patients with cerebral low-grade glioma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[60]  J. Kros,et al.  Prognostic value of the proliferation‐related antigen Ki‐67 in oligodendrogliomas , 1996, Cancer.

[61]  Maurice M. Smith,et al.  Stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimen. , 1989, Neurosurgery.

[62]  K. Shin,et al.  Radiation and chemotherapy improve outcome in oligodendroglioma. , 1997, International journal of radiation oncology, biology, physics.

[63]  B. Scheithauer,et al.  Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[64]  Nancy J Fischbein,et al.  Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. , 2005, AJNR. American journal of neuroradiology.

[65]  Desmond Curran,et al.  Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised Phase III trial on dose response (EORTC trial 22844) , 1998 .

[66]  D. Louis,et al.  Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. , 1998, Journal of the National Cancer Institute.

[67]  A. Karim Cure and Quality of Life After Treatment for Glioma , 1991 .

[68]  Akira Yamaura,et al.  Treatment of low-grade oligodendroglial tumors without radiotherapy , 2004, Neurology.

[69]  J. Crowley,et al.  A randomized trial of radiotherapy versus radiotherapy plus CCNU for incompletely resected low-grade gliomas: a Southwest Oncology Group study. , 1993, Journal of neurosurgery.

[70]  B. Fisher,et al.  Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[71]  E. Shaw,et al.  The practical management of low-grade primary brain tumors , 1999 .

[72]  K. Sepkowitz,et al.  Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[73]  John M Bennett,et al.  Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[74]  F. Scaravilli,et al.  Reliability of histological diagnosis including grading in gliomas biopsied by image-guided stereotactic technique. , 1993, Brain : a journal of neurology.

[75]  I. Whittle,et al.  The dilemma of low grade glioma , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[76]  L. Robison,et al.  High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[77]  E. Zackai,et al.  Brainstem tumors in patients with neurofibromatosis type 1 , 1995, Neurology.

[78]  Damien Galanaud,et al.  Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma. , 2003, Journal of neurosurgery.

[79]  A. Maia,et al.  Stereotactic biopsy guidance in adults with supratentorial nonenhancing gliomas: role of perfusion-weighted magnetic resonance imaging. , 2004, Journal of neurosurgery.

[80]  A. Ramaioli,et al.  Long-term outcome of oligodendrogliomas , 2004, Neurology.

[81]  R. Jain,et al.  Direct Infiltration of Brainstem Glioma Along the Cranial Nerves , 2005 .

[82]  B. Lorenz,et al.  Unilateral adult malignant optic nerve glioma , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.

[83]  T. Gajewski Temozolomide for melanoma: new toxicities and new opportunities. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[84]  E. Alvord,et al.  Gliomas of the optic nerve or chiasm. Outcome by patients' age, tumor site, and treatment. , 1988, Journal of neurosurgery.

[85]  I. Petersen,et al.  Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas. , 1992, Cancer research.

[86]  C. Avezaat,et al.  Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery , 1998, Journal of neurology, neurosurgery, and psychiatry.

[87]  E. Laws,et al.  Low-grade central nervous system tumors. , 2002, Neurosurgical focus.

[88]  P. Kleihues Surgical Pathology of the Nervous System and Its Coverings. Fourth Edition , 2003 .

[89]  S. Bielack,et al.  Combined modality treatment for osteosarcoma occurring as a second malignant disease. Cooperative German-Austrian-Swiss Osteosarcoma Study Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[90]  P. Kelly,et al.  Grading of astrocytomas: A simple and reproducible method , 1988, Cancer.

[91]  G. Krol,et al.  Low-grade oligodendroglioma responds to chemotherapy , 1996, Neurology.

[92]  M. Mehta,et al.  Neurocognitive sequelae of cancer treatment. , 2002, Neurology.

[93]  A. Cianciulli,et al.  Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.